iRhythm Technologies
IRTC | NASDAQ
$90.83
-$1.08 (-1.18%)
At close: Nov 16, 2026, 4:00 PM ET
$90.83
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
iRhythm Technologies Company Profile
Company profile explainedCompany Profile
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
Key Executives
| Name | Position |
|---|---|
| Quentin S. Blackford | President, Chief Executive Officer & Director |
| Brian Lawrence | Executive Vice President & Chief Technology Officer |
| Daniel G. Wilson | Chief Financial Officer & Principal Financial Officer |
| Chad Patterson | Chief Commercial and Product Officer |
| Lisa Pecora | Senior Vice President of Finance & Investor Relations |
| Marc Rosenbaum | Senior Vice President of Finance & Chief Accounting Officer |
| Mervin Smith | Executive Vice President of Business Operations |
| Minang Turakhia | Chief Medical & Scientific Officer and Executive Vice President of Advanced Technologies |
| Patrick Michael Murphy | Chief Business & Legal Officer |
| Sean Clinton Freeman | Executive Vice President of Strategy & Corporate Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 05, 2026 | 8-K | Current Report |
| Sep 22, 2026 | 8-K | Current Report |
| Sep 03, 2026 | 4 | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 13, 2026 | 8-K | Current Report |
| Aug 11, 2026 | 4 | Filing |
| Aug 11, 2026 | 4 | Filing |
| Aug 11, 2026 | 4 | Filing |
iRhythm Technologies
| Country | United States |
| IPO Date | Oct 20, 2016 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 2,400 |
| CEO | Quentin S. Blackford |
Contact Details
699 8th Street San Francisco,
California 94103 United States
Stock Details
| Ticker Symbol | IRTC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001388658 |
| CUSIP Number | 450056106 |
| ISIN Number | US4500561067 |
| SIC Code | 3841 |
Recent News
- 5 days ago / globenewswire.comiRhythm Announces Approval of $200 Million Share Repurchase Program
- 10 days ago / prnewswire.comIRTC Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into iRhythm Technologies, Inc. (IRTC)
- 11 days ago / globenewswire.comiRhythm Holdings to Participate in Upcoming Investor Conferences
- 11 days ago / marketbeat.comWhat iRhythm Technologies (IRTC) Said on Its Q3 Earnings Call
- 11 days ago / seekingalpha.comiRhythm Holdings, Inc. (IRTC) Q3 2026 Earnings Call Transcript
- 11 days ago / zacks.comiRhythm Holdings, Inc. (IRTC) Q3 Earnings Surpass Estimates
- 11 days ago / globenewswire.comiRhythm Holdings Announces Third Quarter 2026 Financial Results
- 19 days ago / zacks.comiRhythm Holdings, Inc. (IRTC) Earnings Expected to Grow: Should You Buy?
- 1 month ago / globenewswire.comiRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026
- 1 month ago / prnewswire.comDid iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Add to Watchlist
Select watchlists to add or remove IRTC